Login:
Share:
Email Facebook Twitter

Epistem ShareCast News (EHP)



ShareCast News for Epistem (EHP)


Share Price: 560.00Bid: 555.00Ask: 570.00Change: -2.50 (-0.44%)Faller - Epistem
Spread: 15.00Spread as %: 2.70%Open: 562.50High: 560.00Low: 555.00Yesterday’s Close: 562.50




Previous Finance News Page
2


Small caps: Titon, Utd Drug, Vernalis...

Blinds specialist Titon's revenues for the 3 months to June were 19% higher than the corresponding period last year, with UK sales 15% higher and the rest of the world 37% higher.
[29 Jul '10]

Epistem FY Trading In line With Market Views, Sees Pretax Profit Up

LONDON (Dow Jones)--Epistem Holdings PLC (EHP.LN), a biotechnology company, said...
[29 Jul '10]

EpiStem breaks even as revenue soars

The Novel Therapies division is threatening to steal the show at epithelial stem cells specialist Epistem, as the benefits of its transformational deal with Swiss pharmaceutical giant Novartis kicks in.
[9 Mar '10]

Small caps round-up: Nautical Petroleum, ThirdForce, Allied Gold...

Oil group Nautical Petroleum reported 'significant progress' in its asset portfolio in the year to June 30 and said it expects its assets to rise in value once they move into the execution stage.
[9 Nov '09]

Douglas sure about Shore

A round-up of the biggest director buys today so far.
[12 Oct '09]

Update: Epistem benefits from raised profile

Drug testing group Epistem moved closer to profit after a research and collaboration deal with the Swiss pharmaceutical giant Novartis helped revenues soar.
[6 Oct '09]

Previous Finance News Page
2



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.